MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) Study

This study, called PRISMS, wants to understand what research topics are most important to people living with myositis diseases like IBM, IIM, Myositis, Inflammatory Myopathy, and Dermatomyositis. Since these are rare diseases, this study aims to gather your perspectives, or those of your care partner, through online open-ended questions, community forums, and surveys. There are no interventions or drugs being tested. The goal is to create a list of research priorities directly from patients to help guide future research and funding decisions. The study is currently unclear on its recruitment status and plans to include about 700 participants.

Study design
This is an observational study that will gather information from about 700 participants. It uses qualitative and mixed methods, mostly online, to understand patient perspectives.
What's involved
You would participate in methods like open-ended narratives, interactive focus groups, forums, and rating/ranking activities. Each activity could last up to 90 minutes.
Compensation
Not stated in the trial record.
Follow-up
Your input will be measured at the completion of your narrative, focus group forum, or survey, up to 90 minutes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07374107

MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)

Recruiting
Not specifiedAges 7+Observational
Myositis International Health & Research Collaborative Alliance Foundation
~700 participants
Updated 2026-01-28 on ClinicalTrials.gov
What's tested:No intervention - qualitative and mixed methods investigations

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient-voiced research priority topics
Measured over At completion of narrative, focus group forum or survey, up to 90 minute
IBM
IIM
Myositis
Inflammatory Myopathy
Dermatomyositis
Dermatomyositis, Juvenile
Anti-synthetase Syndrome
Immune-Mediated Necrotizing Myopathy
Polymyositis
Inclusion Body Myositis
Juvenile Myositis
Juvenile Dermatomyositis
1 sites across 1 states
Louisiana1
  • Lesley Ann Saketkoo, MD, MPH · STUDY_CHAIR · MIHRA Foundation

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Ability to provide informed consent
Have a clinician diagnosis of an idiopathic inflammatory myopathy or be a care partner or parent of a person living with an idiopathic inflammatory myopathy.
Participants who may have signed up through the MIHRA Patient Contact Registry https://mihrafoundation.org/mihra-programs/mihra-patient-contact-registry/

Exclusion

Under the age of 7 years old
Do not have a diagnosis of an inflammatory myopathy
  • Patient-voiced research priority topicsAt completion of narrative, focus group forum or survey, up to 90 minute

    Number and distribution of coded priority domains identified from data collection that has been stratified by disease type, through thematic analysis (codebook refined iteratively) with subsequent assigned degree of importance and ranked priority.